Clinical Trial Update: Phase II Study of Tetrathiomolybdate (TM) in Patients With Breast Cancer [Phase 2]

View source ↗

Summary

A Phase II study of tetrathiomolybdate in breast cancer was terminated; results from the trial have been posted on ClinicalTrials.gov.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Tetrathiomolybdate (tetrathiomolybdate)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Breast Cancer | Phase 2 | Status: TERMINATED | Results posted: 2024-04-23